Processing

Please wait...

Settings

Settings

Goto Application

1. WO2021058919 - METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-ASSOCIATED INFECTION IN A PATIENT

Publication Number WO/2021/058919
Publication Date 01.04.2021
International Application No. PCT/FR2020/051673
International Filing Date 25.09.2020
IPC
C12Q 1/6883 2018.01
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
68involving nucleic acids
6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
6883for diseases caused by alterations of genetic material
CPC
C12Q 1/6883
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS
1Measuring or testing processes involving enzymes, nucleic acids or microorganisms
68involving nucleic acids
6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
6883for diseases caused by alterations of genetic material
C12Q 2600/158
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS
2600Oligonucleotides characterized by their use
158Expression markers
C12Q 2600/16
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS
2600Oligonucleotides characterized by their use
16Primer sets for multiplex assays
Applicants
  • BIOMÉRIEUX [FR]/[FR]
  • BIOASTER [FR]/[FR]
  • HOSPICES CIVILS DE LYON [FR]/[FR]
Inventors
  • VACHOT, Laurence
  • MALLET, François
  • MONNERET, Guillaume
  • MOUCADEL, Virginie
  • PACHOT, Alexandre
  • PERONNET, Estelle
  • RIMMELÉ, Thomas
  • TEXTORIS, Julien
  • VENET, Fabienne
Agents
  • CABINET GERMAIN ET MAUREAU
Priority Data
19/1072327.09.2019FR
Publication Language French (FR)
Filing Language French (FR)
Designated States
Title
(EN) METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-ASSOCIATED INFECTION IN A PATIENT
(FR) PROCÉDÉ POUR DÉTERMINER LE RISQUE DE SURVENUE D'UNE INFECTION ASSOCIÉE AUX SOINS CHEZ UN PATIENT
Abstract
(EN)
The invention relates to an in vitro or ex vivo method for determining the risk of incidence of a care-associated infection in a patient, involving a step of measuring the expression of CX3CR1 in a biological sample from said patient.
(FR)
La présente invention concerne un procédé in vitro ou ex vivo pour déterminer le risque de survenue d'une infection associée aux soins chez un patient, comprenant une étape de mesure de l'expression de CX3CR1, dans un échantillon biologique dudit patient.
Latest bibliographic data on file with the International Bureau